Nutraceutical Industry seeks separate Regulatory Agency

Last Updated on October 19, 2024 by The Health Master

Nutraceutical

Amidst growing concerns about the potential impact of government regulation on the burgeoning nutraceutical industry in India, industry leaders have vehemently opposed the proposal to bring these products under the purview of the Central Drugs Standard Control Organization (CDSCO).

They argue that such a move would stifle innovation, hinder growth, and ultimately harm consumers.

The Need for a Distinct Regulatory Framework

Experts from leading industry associations, including the Indian Pharmaceutical Alliance (IP Alliance) and the Indian Drugs Manufacturers Association (IDMA), have emphasized the need for a separate regulatory mechanism tailored specifically to the unique characteristics of the nutraceutical sector.

They contend that the distinct nature of nutraceuticals, which are primarily dietary supplements rather than drugs, necessitates a regulatory approach that differs significantly from the stringent oversight exercised over pharmaceutical products.

Concerns Over CDSCO Oversight

The industry leaders express grave concerns about the potential negative consequences of placing nutraceuticals under the regulatory umbrella of CDSCO.

They argue that the drug regulator’s focus on safety and efficacy, while essential for pharmaceutical products, may be overly burdensome and restrictive for nutraceuticals. Such a move could stifle innovation, hinder market entry for new products, and ultimately limit consumer choice.

The Role of FSSAI

The Food Safety and Standards Authority of India (FSSAI) has already established a robust framework for regulating the nutraceutical industry.

Industry experts believe that FSSAI is well-equipped to handle the regulatory oversight of these products, given its expertise in food safety and its existing standards and regulations.

They argue that shifting the regulatory authority to CDSCO could undermine the progress made by FSSAI in ensuring the safety and quality of nutraceuticals in India.

Industry’s Call for Government Support

The nutraceutical industry is seeking government support to realize its full potential. Industry leaders are calling for measures that promote innovation, facilitate market access, and foster a conducive regulatory environment.

They believe that a separate regulator, tailored to the specific needs of the nutraceutical sector, would be a crucial step in achieving these objectives.

In conclusion, As the nutraceutical industry in India continues to grow and evolve, the need for a regulatory framework that is both effective and supportive becomes increasingly evident.

Industry leaders are united in their call for a separate regulator to oversee the nutraceutical sector, ensuring its sustainable growth and the safety and quality of products available to consumers.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

• Key Notes on Revised Schedule M: Point No. 11 – Personnel
  December 20, 2024
• USFDA issued Form 483 with two observations to Aurobindo for API plant
  December 20, 2024
• NPPA fixed retail price of 65 formulations: December 2024
  December 20, 2024
• Key Notes on Revised Schedule M: Point No. 10 – Self Inspection
  December 19, 2024
• Medical Device recall: USFDA classifies recall of these catheters as ‘most serious’
  December 19, 2024
• NPPA: New Strategy to Curb Drug Price Hikes
  December 19, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: